2018 and Beyond: Sweden Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Sweden witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Sweden and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Sweden healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Sweden healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Sweden pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Sweden and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Sweden healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Sweden healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Sweden pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Sweden Pharmaceutical and Healthcare Industry Snapshot
2.2 Sweden Pharmaceuticals Market Overview
3 SWEDEN PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Sweden
3.2 Drivers and Restraints
3.2.1 Market Drivers in Sweden Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Sweden Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SWEDEN PHARMACEUTICAL MARKET OUTLOOK
4.1 Sweden Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Sweden Pharmaceutical Exports, $ million, 2015- 2025
4.3 Sweden Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Sweden (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Sweden (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Sweden Prescription Drug Sales, $ Million, 2015- 2025
4.7 Sweden Generic Drug Sales, $ Million, 2015- 2025
5 SWEDEN HEALTHCARE MARKET OUTLOOK
5.1 Sweden Healthcare Expenditure Outlook, 2015- 2025
5.2 Sweden Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Sweden Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Sweden Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Sweden, 2015- 2025
6 SWEDEN HEALTHCARE MARKET STATISTICS
6.1 Sweden Mortality by Disease Category, 2017
6.2 Number of Hospitals in Sweden, 2007- 2017
6.3 Number of Hospital Beds in Sweden, 2007- 2017
6.4 Physicians Count in Sweden, 2007- 2017
6.5 Pharmacists Count in Sweden, 2007- 2017
7 SWEDEN CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Sweden, 2017
7.2 Ongoing Clinical Trials by Disease Category in Sweden, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SWEDEN DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Sweden Population Forecast by Age Group, 2005- 2025
8.2 Sweden Population Forecast by Location, 2005- 2025
8.3 Sweden GDP Forecast, 2005- 2025
8.4 Sweden GDP Per Capita Forecast, 2005- 2025
8.5 Sweden Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SWEDEN PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Sweden Pharmaceutical and Healthcare Industry Snapshot
2.2 Sweden Pharmaceuticals Market Overview
3 SWEDEN PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Sweden
3.2 Drivers and Restraints
3.2.1 Market Drivers in Sweden Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Sweden Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SWEDEN PHARMACEUTICAL MARKET OUTLOOK
4.1 Sweden Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Sweden Pharmaceutical Exports, $ million, 2015- 2025
4.3 Sweden Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Sweden (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Sweden (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Sweden Prescription Drug Sales, $ Million, 2015- 2025
4.7 Sweden Generic Drug Sales, $ Million, 2015- 2025
5 SWEDEN HEALTHCARE MARKET OUTLOOK
5.1 Sweden Healthcare Expenditure Outlook, 2015- 2025
5.2 Sweden Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Sweden Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Sweden Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Sweden, 2015- 2025
6 SWEDEN HEALTHCARE MARKET STATISTICS
6.1 Sweden Mortality by Disease Category, 2017
6.2 Number of Hospitals in Sweden, 2007- 2017
6.3 Number of Hospital Beds in Sweden, 2007- 2017
6.4 Physicians Count in Sweden, 2007- 2017
6.5 Pharmacists Count in Sweden, 2007- 2017
7 SWEDEN CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Sweden, 2017
7.2 Ongoing Clinical Trials by Disease Category in Sweden, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SWEDEN DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Sweden Population Forecast by Age Group, 2005- 2025
8.2 Sweden Population Forecast by Location, 2005- 2025
8.3 Sweden GDP Forecast, 2005- 2025
8.4 Sweden GDP Per Capita Forecast, 2005- 2025
8.5 Sweden Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SWEDEN PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
